Next report date
Report period
Q1 2024
EPS estimate
−0.98USD
Revenue estimate
—
−209.36 MUSD
80.57 M
Om Syndax Pharmaceuticals, Inc.
Sektor
Bransch
VD
Michael A. Metzger
Webbplats
Huvudkvarter
Waltham
Employees (FY)
184
Grundat
2005
FIGI
BBG000R33JY1
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
